S&P 500   2,472.65 (-4.33%)
DOW   21,025.66 (-4.07%)
QQQ   183.62 (-3.56%)
AAPL   243.49 (-4.25%)
FB   160.42 (-3.82%)
MSFT   152.91 (-3.04%)
GOOGL   1,109.47 (-4.52%)
AMZN   1,908.35 (-2.12%)
CGC   13.56 (-6.03%)
NVDA   251.96 (-4.42%)
BABA   187.19 (-3.75%)
MU   40.23 (-4.35%)
GE   7.19 (-9.33%)
TSLA   495.32 (-5.47%)
AMD   44.56 (-2.02%)
T   27.95 (-4.12%)
F   4.43 (-8.48%)
NFLX   362.34 (-3.50%)
BAC   19.76 (-6.97%)
GILD   72.89 (-2.50%)
PRI   83.89 (-5.69%)
DIS   94.73 (-1.94%)
S&P 500   2,472.65 (-4.33%)
DOW   21,025.66 (-4.07%)
QQQ   183.62 (-3.56%)
AAPL   243.49 (-4.25%)
FB   160.42 (-3.82%)
MSFT   152.91 (-3.04%)
GOOGL   1,109.47 (-4.52%)
AMZN   1,908.35 (-2.12%)
CGC   13.56 (-6.03%)
NVDA   251.96 (-4.42%)
BABA   187.19 (-3.75%)
MU   40.23 (-4.35%)
GE   7.19 (-9.33%)
TSLA   495.32 (-5.47%)
AMD   44.56 (-2.02%)
T   27.95 (-4.12%)
F   4.43 (-8.48%)
NFLX   362.34 (-3.50%)
BAC   19.76 (-6.97%)
GILD   72.89 (-2.50%)
PRI   83.89 (-5.69%)
DIS   94.73 (-1.94%)
S&P 500   2,472.65 (-4.33%)
DOW   21,025.66 (-4.07%)
QQQ   183.62 (-3.56%)
AAPL   243.49 (-4.25%)
FB   160.42 (-3.82%)
MSFT   152.91 (-3.04%)
GOOGL   1,109.47 (-4.52%)
AMZN   1,908.35 (-2.12%)
CGC   13.56 (-6.03%)
NVDA   251.96 (-4.42%)
BABA   187.19 (-3.75%)
MU   40.23 (-4.35%)
GE   7.19 (-9.33%)
TSLA   495.32 (-5.47%)
AMD   44.56 (-2.02%)
T   27.95 (-4.12%)
F   4.43 (-8.48%)
NFLX   362.34 (-3.50%)
BAC   19.76 (-6.97%)
GILD   72.89 (-2.50%)
PRI   83.89 (-5.69%)
DIS   94.73 (-1.94%)
S&P 500   2,472.65 (-4.33%)
DOW   21,025.66 (-4.07%)
QQQ   183.62 (-3.56%)
AAPL   243.49 (-4.25%)
FB   160.42 (-3.82%)
MSFT   152.91 (-3.04%)
GOOGL   1,109.47 (-4.52%)
AMZN   1,908.35 (-2.12%)
CGC   13.56 (-6.03%)
NVDA   251.96 (-4.42%)
BABA   187.19 (-3.75%)
MU   40.23 (-4.35%)
GE   7.19 (-9.33%)
TSLA   495.32 (-5.47%)
AMD   44.56 (-2.02%)
T   27.95 (-4.12%)
F   4.43 (-8.48%)
NFLX   362.34 (-3.50%)
BAC   19.76 (-6.97%)
GILD   72.89 (-2.50%)
PRI   83.89 (-5.69%)
DIS   94.73 (-1.94%)
Log in

Regenxbio Earnings Date, Estimates & History (NASDAQ:RGNX)

$29.80
-2.58 (-7.97 %)
(As of 04/1/2020 02:44 PM ET)
Add
Compare
Today's Range
$29.33
Now: $29.80▼
$31.27
50-Day Range
$21.50
MA: $40.10▼
$54.20
52-Week Range
$20.03
Now: $29.80▼
$59.98
Volume23,131 shs
Average Volume705,807 shs
Market Capitalization$1.11 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.88

Earnings

Regenxbio (NASDAQ:RGNX) Earnings Information

Regenxbio last announced its quarterly earnings data on February 26th, 2020. The biotechnology company reported ($0.72) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.44) by $0.28. The firm earned $11.77 million during the quarter, compared to analysts' expectations of $39.67 million. Regenxbio has generated ($3.26) earnings per share over the last year. Regenxbio has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 5th, 2020 based off prior year's report dates.

Regenxbio Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Regenxbio (NASDAQ:RGNX) Earnings Estimates

2020 EPS Consensus Estimate: ($1.14)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.98)($0.98)($0.98)
Q2 20201($0.91)($0.91)($0.91)
Q3 20201($0.86)($0.86)($0.86)
Q4 20201$1.61$1.61$1.61

Regenxbio (NASDAQ RGNX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/5/2020
(Estimated)		       
2/26/2020Q4 2019($0.44)($0.72)($0.72)$39.67 million$11.77 millionTranscript
11/5/2019Q3($0.91)($0.94)($0.94)$7.46 million$14.70 millionTranscript
8/7/2019Q2 2019($0.50)($0.04)($1.40)$5.45 million$7.88 millionListen
5/7/20193/31/2019($0.85)($0.89)($0.89)$0.88 millionTranscript
2/27/2019Q4 2018($0.32)$0.04($0.03)$12.50 million$40.78 millionTranscript
11/7/20189/30/2018($0.86)($0.56)($0.56)$5.31 millionTranscript
8/8/2018Q2 2018$1.90$0.15$100.00 million$40.03 millionN/A
5/8/2018Q1 2018$1.00$3.04$2.96$80.00 million$132.39 millionN/A
3/6/2018Y 2017($0.71)($0.51)($0.51)$2.04 millionTranscript
11/8/2017Q3 2017($0.71)($0.67)($0.67)$1.34 millionN/A
8/8/2017Q2 2017($0.81)($0.47)($0.47)$6.56 millionListen
5/9/2017Q1 2017($0.76)($0.82)($0.82)$0.46 millionListen
3/7/2017Q4 2016($0.60)($0.74)($0.74)$1.70 millionListen
11/9/2016Q3 2016($0.60)($0.69)($0.69)$0.13 millionN/A
8/9/2016Q2 2016($0.52)($0.55)($0.55)$2.38 millionN/A
5/5/2016Q1 2016($0.45)($0.41)($0.41)$0.39 millionN/A
3/3/2016Q4 2015($0.33)($0.20)($0.20)$1.23 million$4.40 millionN/A
11/5/2015Q3 2015($0.35)($1.52)($1.52)$1.10 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 4/1/2020 by MarketBeat.com Staff

Featured Article: Initial Public Offering (IPO)
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel